Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China

Lin ShenDepartment of Clinical Oncology, Beijing Cancer Hospital, Beijing, China;

Qi LiDepartment of Oncology, Shanghai General Hospital, Shanghai, China;

Wei WangDepartment of Oncology, The First People’s Hospital of Foshan, Foshan, Guangdong, China;

Lingjun ZhuDepartment of Oncology, Jiangsu Province Hospital, Nanjing, China;

Qingchuan ZhaoXijing Hospital, Fourth Military Medical University, Xi’an, China;

Yongzhan NieXijing Hospital, Fourth Military Medical University, Xi’an, China;

Bo ZhuInstitute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China;

Dong MaDepartment of Oncology, Guangdong General Hospital, Guangzhou, Guangdong, China;

Xiaoyan LinDepartment of Medical Oncology, Fujian Medical University Union Hospital, Xiamen, Fujian, China;

Xiaohong CaiDepartment of Medical Oncology, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China;

Weijia FangSchool of Medicine, The First Hospital of Zhejiang Province, Hangzhou, Zhejiang, China;

Cike PengHealth Economics and Outcomes Research, Eli Lilly and Company China Affiliate, Shanghai, China;

Yun ChenHealth Economics and Outcomes Research, Eli Lilly and Company China Affiliate, Shanghai, China;

Honghao FangReal World Insights, IQVIA, Shanghai, China;

Zheng YinReal World Insights, IQVIA, Beijing, China;

Hongyan LiHealth Economics and Outcomes Research, Eli Lilly and Company China Affiliate, Shanghai, China;

Ning WangHealth Economics and Outcomes Research, Eli Lilly and Company China Affiliate, Shanghai, China;

Ruihua XuSun Yat-sen University Cancer Center, Guangzhou, Guangdong, ChinaCorrespondence[email protected]

Articles from other publishers (15)